EIM
LAB icon

Essex Investment Management’s Standard BioTools LAB Stock Holding History

Essex Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-55,949
Closed -$689K – 485
2019
Q2 		$689K Buy
+55,949
New +$713K 0.09% 269
2015
Q2 		– Sell
-18,339
Closed -$772K – 327
2015
Q1 		$772K Sell
18,339
-102
-0.6% -$4.03K 0.11% 194
2014
Q4 		$622K Sell
18,441
-2,911
-14% -$82.4K 0.09% 198
2014
Q3 		$523K Sell
21,352
-1,376
-6% -$38.7K 0.08% 217
2014
Q2 		$668K Sell
22,728
-4,775
-17% -$153K 0.1% 220
2014
Q1 		$1.21M Sell
27,503
-5,162
-16% -$227K 0.18% 178
2013
Q4 		$1.25M Sell
32,665
-9,161
-22% -$270K 0.18% 163
2013
Q3 		$918K Buy
+41,826
New +$822K 0.14% 185

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return